Skip to main content
Premium Trial:

Request an Annual Quote

PacBio's Plans for Sequencer Launch Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Feb. 15.

1. PacBio Plans to Sell First DNA Sequencers in 2010; Aims for 100 Gigabases Per Hour (from Feb. 11)

2. VisiGen to Offer 'Nano-Sequencing' Service by 2009 (from Feb. 12)

3. President's Proposed NIH Budget Draws Fire from Scientists, Politicians (from Feb. 15)

4. Acquisitions Boost Qiagen's Q4 Revenues but Hurt Profits (from Feb. 11)

5. Siemens, National Jewish to Collaborate on Personalized Medicine Research (from Feb. 13)

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.